Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifeline Cell Technology, officially incorporated as Lifeline Technologies, Inc., is a biotechnology company specializing in the development and manufacture of advanced human cell culture systems. As a wholly-owned subsidiary of International Stem Cell Corporation (ISCO), the company provides a comprehensive portfolio of high-quality human primary cells, stem cells, and optimized, serum-free growth media. Their products, including the well-known VascuLife and BronchiaLife media lines, are essential tools for pharmaceutical research, toxicology testing, and drug discovery, offering physiologically relevant models that ensure standardized and reproducible results. While Lifeline focuses on the commercialization of life science research tools, its parent company leverages these technologies to develop clinical-stage cell therapies for conditions such as Parkinson's disease and liver disease. The company is headquartered in Walkersville, Maryland, where it maintains GMP-compliant manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifeline Technologies.